Patent details

Basic Information

Publication number:

EP3191472

PCT Application Number:

IB2015056986

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP157666603

PCT Publication Number:

WO2016038581

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

COMPOUNDS AND COMPOSITIONS AS RAF KINASE INHIBITORS

French Title of Invention:

COMPOSÉS ET COMPOSITIONS EN TANT QU'INHIBITEURS DE KINASE RAF

German Title of Invention:

VERBINDUNGEN UND ZUSAMMENSETZUNGEN ALS RAF-KINASE-INHIBITOREN

SPC Number:

Dates

Filing date:

11/09/2015

Grant date:

06/03/2019

EP Publication Date:

19/07/2017

PCT Publication Date:

17/03/2016

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

06/03/2019

EP B1 Publication Date:

06/03/2019

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

11/09/2019

Expiration date:

11/09/2035

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

27/02/2019

 

 

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:

TAFT, Benjamin R.

Address:

United States (US)

2

Name:

RAMURTHY, Savithri

Address:

United States (US)

3

Name:

BURGER, Matthew T.

Address:

United States (US)

Priority

Priority Number:

201462049469 P

Priority Date:

12/09/2014

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/5377; A61P 35/00; C07D 213/74; C07D 403/12; C07D 413/04; C07D 413/14;

Publication

European Patent Bulletin

Issue number:

201910

Publication date:

06/03/2019

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages